FDA Clearance Tracker · P080025-S016
INTERSTIM THERAPY SYSTEMS
Last checked: Nov 20, 2026Latest source record: Apr 10, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Apr 10, 2012
Approved
Time to decision
260 days
Received Jul 25, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080025-S016
- Device name
- INTERSTIM THERAPY SYSTEMS
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Jul 25, 2011
- Decided
- Apr 10, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P080025
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
APPROVAL FOR UPDATING THE LABELING TO ALLOW PARTICULAR TYPES OF MRI SCANS TO BE PERFORMED WHILE THE DEVICES ARE IMPLANTED AND FOR ASSOCIATED CHANGES IN THE PRODUCT SPECIFICATION OF MODEL 3023 INTERSTIM NEUROSTIMULATOR.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.